Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

BLPH

Bellerophon Therapeutics (PK) (BLPH)

Bellerophon Therapeutics Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:BLPH
DateTimeSourceHeadlineSymbolCompany
05/03/202409:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLPHBellerophon Therapeutics Inc (PK)
02/03/202402:04Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
13/02/202407:44Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:BLPHBellerophon Therapeutics Inc (PK)
13/02/202404:39Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialUSOTC:BLPHBellerophon Therapeutics Inc (PK)
13/12/202308:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:BLPHBellerophon Therapeutics Inc (PK)
15/11/202308:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:BLPHBellerophon Therapeutics Inc (PK)
07/11/202308:30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsUSOTC:BLPHBellerophon Therapeutics Inc (PK)
08/02/202004:07Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
30/01/202008:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
28/01/202008:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
08/01/202000:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
28/12/201900:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BLPHBellerophon Therapeutics Inc (PK)
18/12/201900:25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BLPHBellerophon Therapeutics Inc (PK)
26/11/201908:53Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
20/11/201908:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
20/11/201908:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
20/11/201908:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
20/11/201908:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
20/11/201908:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BLPHBellerophon Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:BLPH